EUVIMEDEUVIMED entdecken
Crossref

Fucoxanthin as a Geroprotector: Experimental Data on Mice

A. I. Kapralov, I. Yu. Maklakova, D. Yu. Grebnev, V. V. Bazarnyj, S. I. Krivenko

Ural Medical Journal · 18.08.2026 · 25 (4) · 108-120

DOI: 10.52420/umj.25.4.108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ural Medical Journal, online erschienen am 18.08.2026. Verfasst von A. I. Kapralov und 4 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Th e search for compounds capable of modulating key mechanisms of aging remains one of the pressing challenges of modern medicine. Fucoxanthin, a carotenoid derived from brown algae, possesses antioxidant and anti-infl ammatory properties; however, its eff ects on complex biomarkers of aging in mammals remain insuffi ciently studied. Objective is to comprehensively evaluate the eff ects of long-term oral administration of fucoxanthin on biomarkers of aging, including pro-infl ammatory cytokines, advanced glycation end products, and metabolic parameters in aging mice. Materials and methods . Th e study included 30 male ICR/CD1 mice divided into three groups: 1) mature controls (10 months), 2) aged controls (18 months), and 3) aged mice receiving fucoxanthin (18 months) at a dose of 20 mg/kg body weight per day for 8 months. Serum levels of IL-6, TNF-α, MCP-1, and AGEs, as well as biochemical parameters, were assessed.

Results

In aged control mice, all measured markers were signifi cantly higher than in mature controls. Fucoxanthin administration contributed to a reduction in IL-6, TNF-α, MCP-1, and AGEs levels, along with an improvement in the metabolic profi le (decreased glucose, triglycerides, ALT and AST activities, and increased HDL cholesterol and albumin).

Conclusion

Th e obtained results demonstrate a comprehensive geroprotective eff ect of fucoxanthin, refl ected in suppression of the senescence-associated secretory phenotype, reduction of carbonyl stress, and improvement of metabolic status. Th ese fi ndings support the potential of fucoxanthin as a promising geroprotector for further research in the prevention of age-associated diseases.

Zitieren

APA

Kapralov, A. I., Maklakova, I. Y., Grebnev, D. Y., Bazarnyj, V. V., & Krivenko, S. I. (2026). Fucoxanthin as a Geroprotector: Experimental Data on Mice. Ural Medical Journal, 25(4), 108-120. https://doi.org/10.52420/umj.25.4.108

Vancouver

Kapralov AI, Maklakova IY, Grebnev DY, Bazarnyj VV, Krivenko SI. Fucoxanthin as a Geroprotector: Experimental Data on Mice. Ural Medical Journal. 2026;25(4):108-120. doi:10.52420/umj.25.4.108

BibTeX
@article{Kapralov2026,
  author = {Kapralov, A. I. and Maklakova, I. Yu. and Grebnev, D. Yu. and Bazarnyj, V. V. and Krivenko, S. I.},
  title = {Fucoxanthin as a Geroprotector: Experimental Data on Mice},
  journal = {Ural Medical Journal},
  year = {2026},
  volume = {25},
  number = {4},
  pages = {108--120},
  doi = {10.52420/umj.25.4.108}
}
Kostenlos starten →